Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × daromun × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Carcinoma, Basal Cell 2 Carcinoma 1

Interventions

Cisplatin 43 Carboplatin 38 pembrolizumab 36 Paclitaxel 32 Gemcitabine 27 Pemetrexed 18 Radiotherapy 17 Magnetic Resonance Spectroscopy 17 Radiotherapy, Intensity-Modulated 16 Docetaxel 16 Cetuximab 16 Nivolumab 14 Specimen Handling 13 Cyclophosphamide 13 durvalumab 12 Fluorouracil 12 Sorafenib 10 130-nm albumin-bound paclitaxel 10 Sunitinib 9 Platinum 9 Bevacizumab 9 osimertinib 8 Radiation 8 1,2-diaminocyclohexaneplatinum II citrate 8 Oxaliplatin 7 Irinotecan 7 Everolimus 7 Drug Therapy 7 Capecitabine 7 fludarabine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04362722 2023-10-10

DUNCAN

Philogen S.p.A.

Phase 2 Unknown

Carcinoma, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡